Nel ASA

Nel ASA, a pioneering company established in 1927 and headquartered in Oslo, Norway, delivers comprehensive hydrogen solutions for production, storage, and distribution. Operating across Norway, the United States, Denmark, and South Korea, it sources hydrogen from renewable energy. The company's operations are segmented into two key areas. Its Nel Hydrogen Fueling division develops and supplies H2Station hydrogen fueling solutions, providing fuel cell electric vehicles (FCEVs) – including cars, buses, trucks, and forklifts – with rapid refueling and extensive range, comparable to their fossil fuel counterparts. The Nel Hydrogen Electrolyser segment specializes in the manufacturing and deployment of advanced electrolyzers for hydrogen generation, employing both alkaline and proton exchange membrane (PEM) water electrolysis technologies. This division serves clients in the industrial, energy, and gas sectors. The company, formerly known as DiaGenic ASA, adopted the name Nel ASA in October 2014.

Nel ASA trades as D7G.F on FSX. The company is classified in Industrials / Industrial - Machinery and reports in EUR.

The current profile places the business in Industrial - Machinery. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Nel ASA can be compared against peers such as 2G Energy AG, SFC Energy AG, HOMAG Group AG, ITM Power Plc, ITM Power Plc, Koenig & Bauer AG.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of €516.49M, beta of 1.42, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

D7G.F currently shows total debt of N/A and beta of 1.42. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://nelhydrogen.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.